JP2022545782A5 - - Google Patents
Info
- Publication number
- JP2022545782A5 JP2022545782A5 JP2022510801A JP2022510801A JP2022545782A5 JP 2022545782 A5 JP2022545782 A5 JP 2022545782A5 JP 2022510801 A JP2022510801 A JP 2022510801A JP 2022510801 A JP2022510801 A JP 2022510801A JP 2022545782 A5 JP2022545782 A5 JP 2022545782A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- induction medium
- population
- mesoderm
- differentiation factors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1911957.7A GB201911957D0 (en) | 2019-08-20 | 2019-08-20 | Methods of producing haemogenic progenitor cells from pluripotent stem cells |
| GB1911957.7 | 2019-08-20 | ||
| PCT/EP2020/073396 WO2021032851A1 (en) | 2019-08-20 | 2020-08-20 | Methods of producing haemogenic progenitor cells from pluripotent stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545782A JP2022545782A (ja) | 2022-10-31 |
| JP2022545782A5 true JP2022545782A5 (cg-RX-API-DMAC7.html) | 2023-08-18 |
Family
ID=68099409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510801A Pending JP2022545782A (ja) | 2019-08-20 | 2020-08-20 | 多能性幹細胞から造血性前駆細胞を生産する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220267733A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4017967A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022545782A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220049032A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114269906A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020332863A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022003089A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3150427A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201911957D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL290605A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022001960A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021032851A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11459372B2 (en) | 2020-11-30 | 2022-10-04 | Crispr Therapeutics Ag | Gene-edited natural killer cells |
| EP4271798A1 (en) | 2020-12-30 | 2023-11-08 | CRISPR Therapeutics AG | Compositions and methods for differentiating stem cells into nk cells |
| GB202102297D0 (en) * | 2021-02-18 | 2021-04-07 | Adaptimmune Ltd | Methods of Producing Haemogenic Endothelial Cells from Pluripotent Stem Cells |
| CN113046318B (zh) * | 2021-04-13 | 2023-04-18 | 中国科学院深圳先进技术研究院 | 一种诱导多能干细胞向造血前体细胞分化的培养基以及方法 |
| EP4326852A4 (en) * | 2021-04-22 | 2025-04-23 | Artec Biotech, Inc. | Method for producing hematopoietic cells from stem cells using vascular organoids |
| CN113265377B (zh) * | 2021-06-11 | 2023-01-24 | 中国医学科学院血液病医院(中国医学科学院血液学研究所) | 一种动脉内皮促进功能性t细胞再生的方法 |
| KR102904749B1 (ko) * | 2021-09-10 | 2025-12-30 | 의료법인 성광의료재단 | 전분화능 줄기세포 유래 조혈모세포 제조방법 및 상기 제조된 조혈모세포를 이용한 인간화 마우스 모델 제작방법 |
| CN116376822A (zh) * | 2021-12-31 | 2023-07-04 | 北京大学 | 利用人多潜能干细胞体外制备t淋巴细胞 |
| CN116410927A (zh) * | 2021-12-31 | 2023-07-11 | 士泽生物医药(苏州)有限公司 | 干细胞诱导分化为造血祖细胞的方法 |
| TW202340453A (zh) * | 2022-01-28 | 2023-10-16 | 中國大陸商杭州啟函生物科技有限公司 | 用於基於細胞的免疫療法的方法和組合物 |
| GB202205572D0 (en) | 2022-04-14 | 2022-06-01 | Adaptimmune Ltd | Engineered T cells |
| GB202208545D0 (en) | 2022-06-10 | 2022-07-27 | Adaptimmune Ltd | Production of immune cells |
| CN114958771B (zh) * | 2022-06-27 | 2023-12-05 | 广东康盾创新产业集团股份公司 | 一种ipsc-car-nk细胞的制备方法 |
| CN115247151B (zh) * | 2022-09-21 | 2022-12-27 | 呈诺再生医学科技(北京)有限公司 | 制备造血内皮细胞的方法及制备造血干细胞或造血干祖细胞的方法 |
| KR20240054468A (ko) * | 2022-10-18 | 2024-04-26 | 의료법인 성광의료재단 | 줄기세포에서 대식세포로의 분화 유도용 배지 조성물 및 이를 이용한 분화 방법 |
| CN120303394A (zh) * | 2022-12-02 | 2025-07-11 | 安徽中盛溯源生物科技有限公司 | 用于分化多能干细胞的方法和组合物及衍生的自然杀伤细胞 |
| CN117264888A (zh) * | 2023-10-11 | 2023-12-22 | 苏州艾凯利元生物科技有限公司 | 一种制备造血干细胞和祖细胞的方法 |
| GB202318950D0 (en) | 2023-12-12 | 2024-01-24 | Adaptimmune Ltd | Production of immune cells |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008151390A1 (en) * | 2007-06-15 | 2008-12-18 | Australian Stem Cell Centre Ltd | Differentiation of human embryonic stem cells |
| JP5777115B2 (ja) * | 2010-03-18 | 2015-09-09 | 国立大学法人京都大学 | 多能性幹細胞から中胚葉細胞への分化誘導法 |
| EP2970912B1 (en) * | 2013-03-13 | 2019-03-06 | Wisconsin Alumni Research Foundation | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions |
| WO2015050963A1 (en) * | 2013-10-01 | 2015-04-09 | Manfred Boehm | Human ipsc-derived vascular-related and hematopoetic cells for therapies and toxicology/drug screenings |
| US10626372B1 (en) * | 2015-01-26 | 2020-04-21 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| JP6691921B2 (ja) * | 2015-02-20 | 2020-05-13 | ウィスコンシン アラムニ リサーチ ファンデーション | 動脈内皮細胞集団の生成 |
| US12642852B1 (en) * | 2015-11-04 | 2026-06-02 | Fate Therapeutics, Inc. | Genomic engineering of pluripotent cells |
| CN122146606A (zh) * | 2015-11-04 | 2026-06-05 | 菲特治疗公司 | 用于诱导造血细胞分化的方法和组合物 |
| WO2017192708A1 (en) * | 2016-05-03 | 2017-11-09 | The Children's Medical Center Corporation | Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells |
| US11572544B2 (en) * | 2017-06-14 | 2023-02-07 | The Children's Medical Center Corporation | Hematopoietic stem and progenitor cells derived from hemogenic endothelial cells by episomal plasmid gene transfer |
| SG11202006731VA (en) * | 2018-01-18 | 2020-08-28 | Agency Science Tech & Res | Method for differentiation of human pluripotent stem cell lines in suspension culture |
| GB202006903D0 (en) * | 2020-05-11 | 2020-06-24 | Adaptimmune Ltd | Modified iPSCs |
-
2019
- 2019-08-20 GB GBGB1911957.7A patent/GB201911957D0/en not_active Ceased
-
2020
- 2020-08-20 CA CA3150427A patent/CA3150427A1/en active Pending
- 2020-08-20 US US17/630,882 patent/US20220267733A1/en not_active Abandoned
- 2020-08-20 WO PCT/EP2020/073396 patent/WO2021032851A1/en not_active Ceased
- 2020-08-20 KR KR1020227009012A patent/KR20220049032A/ko active Pending
- 2020-08-20 CN CN202080059222.4A patent/CN114269906A/zh active Pending
- 2020-08-20 EP EP20761193.0A patent/EP4017967A1/en not_active Withdrawn
- 2020-08-20 MX MX2022001960A patent/MX2022001960A/es unknown
- 2020-08-20 BR BR112022003089A patent/BR112022003089A2/pt unknown
- 2020-08-20 AU AU2020332863A patent/AU2020332863A1/en not_active Abandoned
- 2020-08-20 JP JP2022510801A patent/JP2022545782A/ja active Pending
-
2022
- 2022-02-14 IL IL290605A patent/IL290605A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022545415A5 (cg-RX-API-DMAC7.html) | ||
| JP7560502B2 (ja) | 多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法 | |
| US12241087B2 (en) | Compositions and methods for differentiating stem cells into NK cells | |
| JP6344821B2 (ja) | 造血前駆体の集団および造血前駆体のための幹細胞を富化する方法 | |
| US9771561B2 (en) | Method of making primate cells expressing apelin receptor that have mesangioblast potential | |
| JP2024507472A5 (cg-RX-API-DMAC7.html) | ||
| Netsrithong et al. | Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation | |
| JP2022545078A5 (cg-RX-API-DMAC7.html) | ||
| KR20180063333A (ko) | 면역 세포로의 만능 줄기 세포의 지정된 분화 방법 | |
| CN107429230A (zh) | 用于诱导造血细胞分化的方法和组合物 | |
| CA2905786A1 (en) | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions | |
| IL305018A (en) | Methods of producing haemogenic endothelial cells from pluripotent stem cells | |
| Galić et al. | Generation of T lineage cells from human embryonic stem cells in a feeder free system | |
| JP2022545416A5 (cg-RX-API-DMAC7.html) | ||
| Lu et al. | Enhanced generation of hematopoietic cells from human hepatocarcinoma cell− stimulated human embryonic and induced pluripotent stem cells | |
| Liu et al. | Progress and challenges in generating functional hematopoietic stem/progenitor cells from human pluripotent stem cells | |
| Philonenko et al. | Recapitulative haematopoietic development of human pluripotent stem cells in the absence of exogenous haematopoietic cytokines | |
| Gong et al. | Interplay of transcription factors and microRNAs during embryonic hematopoiesis | |
| Lee et al. | Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells | |
| CN115087732B (zh) | 来自人T细胞来源的iPS细胞的细胞毒性T细胞 | |
| US20240191189A1 (en) | Reagents and methods for producing arterial hemogenic endothelium, hematopoietic progenitors, and lymphoid cells thereby | |
| Wang | Endothelial and hematopoietic cell fate of human embryonic stem cells | |
| WO2023233339A1 (en) | Compositions and methods for differentiating stem cells into nk cells | |
| RU2022107099A (ru) | Культуральная среда для гемопоэтической индукции | |
| Moore et al. | Hematopoietic cells |